September 3, 2020
Biofourmis, a Boston-based predictive-care startup that's leaning more and more into digital therapeutics, has wrapped up $100 million in Series C financing. The raise was led by SoftBank Vision Fund 2, and also saw contributions from prior backers Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI.
With this major jump from last May's $35 million Series B, the company is now...
July 23, 2020
Japanese pharmaceutical giant Chugai and Boston-based digital therapeutics company Biofourmis announced that they have partnered to develop a digital solution for the objective assessment of pain associated with endometriosis.
Affecting one out of 10 women in their 20s to 40s, endometriosis is the repeated proliferation and shedding of endometrial tissue outside the uterus, accompanied by...
June 11, 2020
Telehealth vendor MDLive has tapped Dr. Cynthia Zelis as its new chief medical officer. She comes from University Hospitals in Cleveland, where she actually handled the system's rollout of the MDLive's services while serving as VP of ambulatory operations and telehealth. That role tasked her with oversight of more than 50 ambulatory health centers and all of the system's telehealth efforts.
April 16, 2020
Remote-monitoring and decision-support startup Biofourmis is set to acquire Takeda Pharmaceuticals’ Gaido Health, an oncology-focused digital tool, for an undisclosed sum. The new cash deal is expected to help Biofourmis further its foothold on the oncology space.
“When we started Biofourmis, our primary focus was cardiovascular disease. The goal from the beginning was to continue to expand our...
January 29, 2020
New York-based startup Nomad Health, a company that makes an online platform for healthcare job-seekers and employers, has appointed Liming Zhao as its first chief technology officer. Previously holding similar posts at Frontier Signal (which he cofounded) and Compass, Zhao will be heading up the employment marketplace’s engineering, data science, IT and security efforts, and will also be helping...
November 20, 2019
Sanofi is merging its real-world data platform with New York startup Aetion’s similar evidence platform to augment its treatment development and deployment efforts, the companies announced today. Sanofi’s DARWIN platform will provide a substantial body of de-identified patient data, which the Aetion Evidence Platform will analyze those information for insights on drug effectiveness, safety and...
November 18, 2019
This morning Biofourmis, maker of an artificial intelligence-enabled monitoring and decision support platform, announced its plans to acquire Zürich, Switzerland-based wearable biosensor company Biovotion. The terms of the deal are not disclosed; however, we do know the deal is made up of a combination of cash and equity.
The acquisition will include Biovotion’s clinical grade-wearable...
May 21, 2019
This morning, artificial-intelligence-enabled monitoring and decision support platform Biofourmis announced a $35 million Series B raise. The round was led by Sequoia India and MassMutual Ventures with participation from EDBI, Jianke and existing investors Openspace Ventures, Aviva Ventures and SGInnovate.
The funding announcement coincided with the news that the Singaporean company will be...
May 2, 2019
The FDA has granted 510(k) clearance to Biofourmis’ RhythmAnalytics, a cloud-based software product that uses deep learning to read and interpret cardiac arrhythmias.
According to a statement from the company and the FDA’s clearance letter, RhythmAnalytics collects single-lead ECG data from a range of FDA-cleared devices, and from these scan for more than 15 types of cardiac arrhythmias,...